| Tag | Content |
|---|
EnhancerAtlas ID | HS173-07410 |
Organism | Homo sapiens |
Tissue/cell | SH-SY5Y |
Coordinate | chr2:39333850-39335870 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr2:39334602-39334620 | CCTTCCTTCCTTACCTCT | - | 6.73 | | EWSR1-FLI1 | MA0149.1 | chr2:39334598-39334616 | AGTTCCTTCCTTCCTTAC | - | 6.75 | | RUNX1 | MA0002.2 | chr2:39334074-39334085 | GTTTGTGGTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_00320 | chr2:39333685-39335364 | Adipose_Nuclei | | SE_13832 | chr2:39334166-39335054 | CD34_Primary_RO01536 | | SE_18578 | chr2:39333693-39335802 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 39334288 | 39334718 | | chr2 | 39335032 | 39335193 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I039107 | chr2 | 39334341 | 39334542 |
|
Enhancer Sequence | CAGAATTTGA CATTCTGAGG AATTTCATTC ACTGGTTTGC GCCTTTCTGC CTGTGAGGTA 60
GCCCAGACTA GCAAGGAAAA CCAACAAGGA GTCATCTTCG TGGCCACATG GTTGGACTAT 120
TCACGAACTT ACTGCTGGTT TGCCTCAAGT ACTCCTGGTT CACCAGTTCA TAGAGTAAAA 180
ATTTGGGGTG TTACTTGAAT TGTTTTCTTT TGTCTTACTG TTCTGTTTGT GGTTTTGCAT 240
ATTAAGTATT TAATTACATA AACATTGAAT ATGAATGCAA AGTTTATATG ATTAGCTACT 300
GAAGTAAATT GTGTACCATT AATTTCAATG AAAATTAATT TCTGACTTTT AAGAATTCAC 360
CTTAAGGCAT CCTTTTTTTT TTCTTTTAAA TACAGGGGTT TTTTGGGAAC AAATTACCCA 420
CCTGAAATGG GGAAAAACTG TACTTTATCC CGAATTAGGC AATTCATAGC CAGAGATGAC 480
CCTAATTGAT CATGAGAACG AGCCTCTCAG ATCTCTGACT ACAGGAAGGA TAATAGACTG 540
AGTGCTGCAG CAGCTGCACT CAAATCCATC ACTGTGTTTG TGTCGAGGCC AGTTTCTCAC 600
TAGCTCCTCC CAGTCACTGA CTGAGCATGG CAGGCCTGTT CCCGGGAGAC ACATCATTTT 660
TCCAACAGGC ACCTTTCACT CAAAGACTTT CTGAGGCCTT GCAAACTTTC CTTAGTATTG 720
CACTACAGTC TAAGACACTT TCACTCAAAG TTCCTTCCTT CCTTACCTCT CTTTTAACTT 780
GGAGTCAGAC TTTCATCAGT CTGACAACTC TCCCTGTCTC CTTCCTTTTC CCCCCTCACA 840
AGCATTTCAC CTAACAAATT TCTTATGTGC TTAATCCCAT CTTGGCATCT GCTTCTAAGA 900
GGTCCTGGAC TAATACAATG ACAAAGGCTC CCCTTGAAGC ATCACACTAA AAAGAAAAAA 960
AAAAAAAAAA AACCTAGCCA TTTTACATTA ACTATTTCTA AAATATAGTA TTTGCTTCCC 1020
TATTTGCTAA AACAAAATAT ACTAAACATG ACTATTCCAA AATTCTGTAG GTACTAAGAA 1080
TATGAAGAGA TTCACTCTAC TCAGGGGATG GAGTTGTAGT AGAAAGGCTT TGTGGAGGAG 1140
GTGGTGTTTG AAATGTACTT TAGAGCCATC CTCAAAGCCT TGAGGCTATA CCTGCCTGTG 1200
ATTATCAAGG ACAGTCCATC AAACAGGCCT TCCACGCTTG GATATCTGCC AAAGAGTAAA 1260
TCCCTCCTAT CACAATTCTC TCACAGCCCT CTAATCTCTA GAATACTGAT GGTGCCTTAG 1320
TCTCCCTCCA AACGTGATCC TCTCCCAATA TTCCCCCTTT CATCACCATC CCCACTTAGA 1380
CACCTCAGTC AGAAACCTGG GAATCCTCTC ACTGCCCTGC TCAATTCAAT CACCAATCTG 1440
CCTCTAAATC TCTCTAATTA ATTTGTCCAC TTTTCTCCAT CCCCACAGCT ACTGCTCTAA 1500
TCAAAGCCAC CTATCATCCC TTCCATGAAC TACTGCAAAA TCTCCTCAAC TGGCTTTCCT 1560
GCCTACAGTT CAGTTCCCAT TTAATCCATG CTCCATACAG TCTACAGCAG TCCTTCAAAA 1620
TTCATGTGTG TCAGTTCCCT GCTTAAAACC CTGCAGTTGC TCCCCACTGC TGACAAGATA 1680
AAATGCAATA ATTTGATTCA CACGATCTGG CCCCCACTCC AGACTTCAGC TACTCAGAAC 1740
TCCAAAAATG CTGAGTTCCT CTTGGCCTCC AAGCTACCAC AAATCCTTGG AATTTATTTC 1800
CTCCTAATCC TTAACTGGCT AACTCTCATT TCCATTCACT CATTCATTCA TTCATTCACC 1860
CATTTATGGT CCCACTTCCA TTTAAAAAGT CACTTCTGGC CAGGCACAGT GGCTCACTCC 1920
TGTAATCCCA GTGCTTTGGG AGGCCAAGGC AGGAGGATCA CTTGAGGCCA GGAGTGTGAA 1980
ACCAGCCTGA GTAACACAGT GAGACCCTGT CTCTACAAAA 2020
|
